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ARTICLE
A tunable dual-input system for on-demand
dynamic gene expression regulation
Elisa Pedone1,2*, Lorena Postiglione1,2,11, Francesco Aulicino3,4,11, Dan L. Rocca1,2,3*, Sandra Montes-Olivas1,
Mahmoud Khazim1,2, Diego di Bernardo 5, Maria Pia Cosma6,7,8,9,10 & Lucia Marucci1,2,3*
Cellular systems have evolved numerous mechanisms to adapt to environmental stimuli,
underpinned by dynamic patterns of gene expression. In addition to gene transcription
regulation, modulation of protein levels, dynamics and localization are essential checkpoints
governing cell functions. The introduction of inducible promoters has allowed gene expres-
sion control using orthogonal molecules, facilitating its rapid and reversible manipulation to
study gene function. However, differing protein stabilities hinder the generation of protein
temporal profiles seen in vivo. Here, we improve the Tet-On system integrating conditional
destabilising elements at the post-translational level and permitting simultaneous control of
gene expression and protein stability. We show, in mammalian cells, that adding protein
stability control allows faster response times, fully tunable and enhanced dynamic range, and
improved in silico feedback control of gene expression. Finally, we highlight the effectiveness
of our dual-input system to modulate levels of signalling pathway components in mouse
Embryonic Stem Cells.
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A number of perturbation approaches have been developedto study gene function in biological systems, and for genetherapy applications. It has become increasingly clear that
gene expression patterns in vivo are fast and highly dynamic
processes, encoding important time-dependent information that
underlies many aspects of cellular behaviour1. Thus, precise
temporal control, as well as reversible manipulation of exogenous
gene expression, are fundamental for interrogating cellular
functions2.
Temporal control of gene expression can be achieved by
transcriptional regulation via inducible promoters3–6. The most
widely used system for transcriptional regulation is the Tet
system, which consists of the tetracycline transcriptional acti-
vator (tTA) and the DNA operator sequence (tetO)7–11. The
tTA is a fusion protein of the herpes simplex virus VP16 acti-
vation domain and of the Escherichia coli Tet repressor protein
(TetR)8. The presence of tetracycline or its derivative doxycy-
cline prevents the interaction of the tTA with the tetO, blocking
gene expression (Tet-Off system). The reverse-tTA (rtTA) is a
tTA variant allowing gene expression activation in presence of
an inducer; the resulting Tet-On system is generally preferred
when rapid and dynamic gene induction is required3,12. A
major limitation of inducible promoters is the significant time
delay in switching proteins OFF and ON when using Tet-On
and Tet-Off systems, respectively13, diminishing the possibility
of using these approaches to generate dynamic patterns of gene
expression that faithfully recapitulate those observed natively1.
Slow kinetic responses are also common to other techniques
targeting precursor DNA or mRNA molecules (e.g. RNA
interference14), likely due to significantly different rates of
innate protein degradation14.
Recently, an approach relying on conditional protein destabi-
lization to modulate turnover by the cellular degradation
machinery has been harnessed to probe biological functions.
Engineered mutants of FKBP12 that are rapidly and constitutively
degraded in mammalian cells can directly confer destabilisation
to the protein they are fused with. The addition of synthetic
ligands that bind the Destabilising Domain (DD) of FKBP12
prevents degradation and so can be used to alter levels of the
fused-protein of interest15.
Whilst significantly enhancing the switch-off kinetics as com-
pared to Tet-On, conditional protein regulation systems do not
allow independent control of both transcription and translation,
which would be highly desirable when studying the correlation
between protein and cognate mRNA levels under different spatial
and temporal scales16.
To overcome these limitations, here we present a fully
tuneable dual-input system, which allows orthogonal and
conditional control at both transcriptional and post-
translational levels of a gene of interest. Specifically, we com-
bine a third generation Tetracycline-Inducible System (Tet-On
3 G)11,17 for inducible and reversible transcriptional regulation
with a module incorporating an improved DD from ecDHFR18
for targeted protein degradation. We demonstrate that
our system permits far greater control of both protein
dynamics and expression dynamic range across different cul-
ture platforms, including microfluidics used for in silico
feedback control, and mammalian cell lines. Moreover, we
develop an ordinary differential equation model capturing
the enhanced dynamic response to inducers. The efficacy of
conditional dual-input regulation is exemplified by the
ability to incorporate different genes of interest, such as
fluorescent proteins and Wnt pathway components, in com-
plex cellular chassis (e.g. mouse embryonic stem cells), paving
the way for dynamically controlling mammalian cell behaviour
and fate.
Results
Dual-input orthogonal regulation of gene expression. We
engineered a mouse Embryonic Stem Cell (mESC) line to stably
express the reverse tetracycline transcriptional activator con-
struct (rtTA) and a stable mCherry (henceforth EF1a-rtTA_-
TRE3G-mCherry; Fig. 1a), or conditionally destabilised
DDmCherry (henceforth EF1a-rtTA_TRE3G-DDmCherry;
Fig. 1c) under the control of a TRE3G promoter, which tran-
scribes the gene of interest only in presence of the tetracycline
analogue doxycycline11 (Doxy; Fig. 1a, c). Post-translational
control is achieved by applying the small molecule trimetho-
prim (TMP), which stabilises the destabilising domain (DD)-
fused protein in a dose-dependent manner18. These two con-
structs allow for comparison of the standard Tet-On with the
dual-input Tet-On/DD system we developed.
We exposed EF1a-rtTA_TRE3G-mCherry and EF1a-
rtTA_TRE3G-DDmCherry mESCs to saturating concentra-
tions of Doxy (1000 ng/mL) and TMP (100 nM) for 24 h and
checked for mCherry mRNA (Fig. 1b, d, left panels) and
protein (Fig. 1b, d, right panels) levels. In absence of Doxy,
both transcription and protein expression were undetectable,
demonstrating no promoter leakiness (Fig. 1b, d; −Doxy and
−Doxy/+TMP samples, respectively), whereas mCherry was
robustly activated at both mRNA and protein levels following
Doxy and TMP administration (Fig. 1b, d; +Doxy and +Doxy/
±TMP, respectively). Notably, Doxy and TMP selectively
control transcription and protein stability, respectively: when
TMP is combined with Doxy, mCherry mRNA is unchanged
(Fig. 1d; left panel), whereas a clear increase in protein stability
is observed (Fig. 1d; right panel).
To quantitatively estimate the effect of inducers on protein
stability, we measured protein half-life in both EF1a-
rtTA_TRE3G-mCherry and EF1a-rtTA_TRE3G-DDmCherry
mESCs. Cells were cultured in presence of Doxy and Doxy/
TMP for 14 h, and then plated in presence of the protein
synthesis inhibitor cycloheximide with varying combinations of
Doxy and TMP for 8 h; mCherry was measured by western-blot
over the time-course (Fig. 1e). In EF1a-rtTA_TRE3G-mCherry
mESCs, untagged mCherry showed no response to inducers,
and the half-life was similar across conditions (Fig. 1f;
Supplementary Fig. 1a). Of note, mCherry mRNA decreased
following Doxy withdrawal (Supplementary Fig. 1c), confirm-
ing no effect of Doxy or TMP on protein stability in this system.
In contrast, the half-life of the conditionally destabilised
mCherry increased approximately three fold in presence of
TMP, independently of Doxy addition (Fig. 1g; Supplementary
Fig. 1b; +Doxy/+TMP and −Doxy/+TMP samples). mRNA
levels decreased only when Doxy was removed (Supplementary
Fig. 1d), further demonstrating the specific and independent
effect of the two inducers.
Consistently, we found that MG132 blockade of the protea-
some19 enhanced DDmCherry stability, suggesting that TMP acts
by preventing proteasomal degradation of DD-fused proteins
only18 (Supplementary Fig. 1e). Indeed, both MG132 and TMP
treatment increased DDmCherry abundance, whereas levels of
the native β-catenin protein, whose degradation is proteasome
mediated20, increased only when proteasomal activity was
inhibited (Supplementary Fig. 1e). Analysing the polyubiquitina-
tion status of DDmCherry, following inducer removal and
chasing with or without TMP for 12 h, indicated that TMP likely
limits addition of ubiquitin chains or promotes de-ubiquitination
of DD-tagged proteins, ultimately preventing proteasomal
degradation (Supplementary Fig. 1f).
Altogether, these data show that our system allows robust
control of both gene transcription and protein stability, with
undetectable leakiness and specific response to inducers.
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Dual-input system tunability and dynamic response. To gauge
the tunability and sensitivity of our inducible system, as well as its
suitability for dynamic modulation of a gene of interest, we
performed both switch-on steady-state titration experiments and
switch-off time-courses upon drug administration and removal,
in EF1a-rtTA_TRE3G-mCherry and EF1a-rtTA_TRE3G-
DDmCherry mESCs.
EF1a-rtTA_TRE3G-mCherry mESCs incubated with six dif-
ferent concentrations of Doxy for 24 h and analysed by flow-
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inducer, with saturation reached at Doxy 100 ng/mL (Fig. 2a,
dots; Supplementary Fig. 2a); EF1a-rtTA_TRE3G-DDmCherry
mESCs showed similar steady-state response when kept with
maximal concentration of TMP (10 μM) and varying Doxy in the
same range (Fig. 2b, dots; Supplementary Fig. 2b). Also, TMP
showed a robust dose-dependent effect when varied while keeping
Doxy at maximal concentration (Fig. 2c, dots; Supplementary
Fig. 2b).
To complement these experiments, we developed a mathema-
tical model to capture the behaviour of the dual-input system: we
relied on ordinary differential equations (ODEs), commonly used
to model interactions among genes and other relevant processes,
such as mRNA/protein degradation, basal promoter activity and
mRNA translation21,22. The mathematical models for the EF1a-
rtTA_TRE3G-mCherry and EF1a-rtTA_TRE3G-DDmCherry
systems are based on sets of three ODEs, describing transactivator
and fluorescent gene concentrations as the result of production
and degradation terms, and inducer action (Supplementary
Note 1). The TET system was modelled, as previously proposed,
using Hill kinetics to represent the effect of the inducer on
trascription23. Given the observed saturating response to TMP
(Fig. 2c, dots; Supplementary Fig. 2b and18), a Hill function,
dependent on TMP, was incorporated in the DDmCherry protein
degradation term (Supplementary Note 1). To estimate para-
meters (Supplementary Table 1 and Note 1), the two ODE models
were fitted to the aforementioned steady-state switch-on experi-
mental data and showed good agreement (Fig. 2a–c, dashed lines,
Root Mean Squared Error -RMSE- in Fig. 2a–c legends).
Next, we used the fitted models to predict the switch-
off dynamic response of both the Tet-On and the Tet-On/
DD systems upon inducer withdrawal; model simulations
indicated much faster switch-off of the dual-input system (Fig. 2d,
e, dashed lines). These predictions were validated experimentally:
both EF1a-rtTA_TRE3G-mCherry and EF1a-rtTA_TRE3G-
DDmCherry mESCs were able to reach full steady-state induction
upon 14 h of incubation with Doxy and Doxy/TMP, respectively,
with the conditionally destabilised mCherry showing 80%
protein reduction 8 h after inducer removal, as compared to
40% reduction only in the Tet-On system (Fig. 2d, e, dots;
Supplementary Fig. 2c, d). When EF1a-rtTA_TRE3G-
DDmCherry mESCs were induced with Doxy only, the switch-
off dynamics upon Doxy removal were faster than in the EF1a-
rtTA_TRE3G-mCherry cells (Supplementary Fig. 2c, d); this is
expected, as the DDmCherry protein, in absence of TMP, has
lower half-life than mCherry (Fig. 1f, g). However, this also
caused cells to present lower mCherry expression upon activation,
thus reducing the dynamic range upon induction (Supplementary
Fig. 2d).
To assess the response to drugs at single cell level, we analysed
the switch-on and -off transitions of 13 individual clones FACS-
sorted from both EF1a-rtTA_TRE3G-mCherry and EF1a-
rtTA_TRE3G-DDmCherry populations (Supplementary Fig. 2e,
f, respectively). Both the switch-on and -off responses were more
homogenous across clones in EF1a-rtTA_TRE3G-DDmCherry
cells, as indicated by the mCherry-expressing cell coefficient of
variation (Supplementary Fig. 2g); this suggests that conditional
control of protein stability might reduce cell-to-cell variability.
These results indicate that the dual-input system we developed
allows fully tunable protein induction with both drugs, and faster
switch-off dynamics as compared to a standard Tet-On system.
Furthermore, the model satisfactory replicated experimental data,
indicating that Hill kinetics suit modelling Destabilising Domain
responses, for which a mathematical formalism has been missing.
Modular control and dynamic range. Given the improved
dynamic response of the conditionally destabilised mCherry in
EF1a-rtTA_TRE3G-DDmCherry mESCs, we reasoned about
further exploiting the performance of the inducible system by
fusing the rtTA with a Destabilising Domain. Therefore, we
generated two additional mESC lines constitutively expressing a
conditionally destabilised version of the rtTA in combination
with either a stable or a conditionally destabilised mCherry
(Supplementary Fig. 2h, i; EF1a-DDrtTA_TRE3G-mCherry and
EF1a-DDrtTA_TRE3G-DDmCherry, respectively).
Both cell lines responded to Doxy/TMP treatment at steady-
state, and Doxy and TMP titration experiments indicated good
response of mCherry to both drugs (Supplementary Fig. 2j–m, p
and q). As expected, when DD is present on both the
transactivator (rtTA) and the fluorescent reporter, the residual
protein stability when the mRNA is transcribed is reduced
(compare +Doxy/−TMP samples in Supplementary Fig. 2b, q).
The fitting of two new ODE systems, describing EF1a-
DDrtTA_TRE3G-mCherry and EF1a-DDrtTA_TRE3G-
DDmCherry mESC dynamics consistently with the aforemen-
tioned modelling assumptions (Supplementary Note 1 and
Table 2), showed good agreement with experimental data
(Supplementary Fig. 2j–m, dashed lines and dots represent model
fitting and experimental data, respectively, RMSE in Supplemen-
tary Fig. 2j–m legends).
In time-course experiments, both EF1a-DDrtTA_TRE3G-
mCherry and EF1a-DDrtTA_TRE3G-DDmCherry mESCs
switched-off the fluorescent reporter upon inducer removal faster
than cells carrying the standard Tet-On system (compare
Supplementary Fig. 2n, o -dots representing data in Supplemen-
tary Fig. 2r, s- and Fig. 2d). As compared to the EF1a-
rtTA_TRE3G-DDmCherry system, the DD presence on both
the destabilising domain and mCherry did not further reduce the
switch-off time, (compare data in Supplementary Fig. 2o and in
Fig. 2e); validation of the models on time-course data
(Supplementary Fig. 2n, o, dashed lines) confirmed these results.
We argue that the observed switch-off dynamics are caused by a
partial persistence of protein stability despite TMP removal, as
also previously shown by blocking protein synthesis in EF1a-
rtTA_TRE3G-DDmCherry mESCs in absence of TMP (Fig. 1g;
Supplementary Fig. 1b). Furthermore, EF1a-DDrtTA_TRE3G-
Fig. 1 Dual-input regulation of exogenous protein expression. a–d Dual-input regulation system consisting of the reverse transactivator (rtTA) and a stable
(a) or conditionally destabilised (c) mCherry fluorescent protein. mRNA (b, d, left panels) and protein levels (b, d, right panels) measured in EF1a-
rtTA_TRE3G-mCherry (b) and EF1a-rtTA_TRE3G-DDmCherry (d) mESCs treated for 24 h with Doxy (1000 ng/mL) or Doxy/TMP (1000 ng/mL and
100 nM, respectively). e Experimental scheme of protein half-life measurement. Following 14 h of treatment with Doxy (1000 ng/mL) or Doxy/TMP
(1000 ng/mL and 100 nM, respectively), EF1a-rtTA_TRE3G-mCherry and EF1a-rtTA_TRE3G-DDmCherry mESCs were cultured in presence of the protein
synthesis inhibitor cycloheximide (CHX, 25 μg/mL) and combination of Doxy (1000 ng/mL), TMP (100 nM) and Doxy/TMP. Protein half-life was
measured by western blot after the indicated times of treatment. f, gWestern blot densitometric quantification of EF1a-rtTA_TRE3G-mCherry (f) and EF1a-
rtTA_TRE3G-DDmCherry (g) mESCs. Plotted mCherry and DDmCherry values are normalised against the housekeeping gene GAPDH. Data are means ±
SEM (n= 2, b and d; n= 3, f and g). p values from two-tailed unpaired t test (b, d) and nonparametric one-way ANOVA (f, g) are shown. Source data are
provided as a Source Data file
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DDmCherry mESCs showed reduced activation in presence of
both Doxy and TMP (compare Supplementary Fig. 2b and q),
possibly due to limited TMP efficacy in stabilising both DDrtTA
and DDmCherry.
Nevertheless, the dual-input control system allows fully tunable
dynamic range of protein levels, as shown by dose-response
model simulations (Fig. 2f; Supplementary Fig. 2t, v). We
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of Doxy and TMP in EF1a-rtTA_TRE3G-DDmCherry,
EF1a-DDrtTA_TRE3G-mCherry and EF1a-DDrtTA_TRE3G-
DDmCherry mESCs and found a robust dose-response increase
in mCherry protein levels (Fig. 2f; Supplementary Fig. 2t, v).
Experimental validation of model simulations (Fig. 2g; Supple-
mentary Fig. 2u, w) confirmed both validity of the models, and
the ability of tightly controlling the exogenous protein dynamic
range when modulating both drugs.
We also proved the functionality of our dual-input system in a
different mammalian cell line. We stably transduced HeLa cells
with mCherry (henceforth HeLa_EF1a-rtTA_TRE3G-mCherry)
or the conditionally destabilised DDmCherry (henceforth
HeLa_EF1a-rtTA_TRE3G-DDmCherry) inducible constructs.
HeLa cells showed good dose-response in steady-state activation
(Supplementary Fig. 2x); the overall reporter intensity was higher
than in mESCs (compare Supplementary Fig. 2b with 2x),
possibly due to different transduction efficiency and/or to cell
line-specific transcription, translation and degradation machin-
ery. From titration experiments, we selected Doxy100ng/mL and
TMP 10 nM to run a switch-off time-course. As in mESCs,
protein stability control enabled faster On-Off transition:
HeLa_EF1a-rtTA_TRE3G-DDmCherry cells showed 50% protein
reduction 8 h after inducer removal, while HeLa_EF1a-
rtTA_TRE3GmCherry cells still presented 70% of maximal
mCherry expression after 24 h from inducer removal (Supple-
mentary Fig. 2y, z). We observed an increase in mCherry
expression in HeLa_EF1a-rtTA_TRE3G-mCherry after inducer
withdrawal (Supplementary Fig. 2y), not notable in EF1a-
rtTA_TRE3G-mCherry mESCs (Supplementary Fig. 2c) or
HeLa_EF1a-rtTA_TRE3G-DDmCherry (Supplementary Fig. 2z);
this might be due to cell type-specific Doxy metabolism (e.g.
uptake, clearance), compensated by the DD presence. These data
further confirm the suitability of the dual-input control system to
achieve robust modulation of protein levels across cell species.
In silico feedback control using dual-input regulation.
Recently, successful attempts have been made to dynamically
regulate gene expression patterns in living cells, applying control
engineering paradigms and using microfluidics or optogenetics
platforms for dynamic cell stimulation, and microscopy or flow
cytometry for obtaining real-time cell read-outs.24–33. Applica-
tions in mammalian cells have been recently attempted25, con-
trolling a Tet-Off promoter-driven fluorescent protein using
tetracycline as control input; this pioneering work showed feasi-
bility of the in silico feedback control action, but highlighted
challenges in controlling a system with slow kinetic response.
We wondered if our dual-input system would allow finer
in silico gene expression feedback control using a microfluidic/
microscopy platform (Supplementary Fig. 3); thus, we tested the
effectiveness of individual gene transcription or protein stability
regulation as compared to their combined modulation. EF1a-
rtTA_TRE3G-DDmCherry mESCs, Doxy/TMP treated, showed
the same activation profile of EF1a-rtTA_TRE3G-Cherry mESCs
(Supplementary Fig. 2a, b, Doxy and Doxy/TMP respectively);
thus, in silico feedback control experiments were performed on
EF1a-rtTA_TRE3G-DDmCherry mESCs only using different
combination of control inputs. Specifically, for set-point control
experiments (Supplementary Fig. 3), we applied a Relay control
strategy to reduce protein expression to 50% of the maximal
induction reached upon overnight treatment with combined
Doxy and TMP (set-point control reference, Supplementary
Note 2)25. Control inputs were: time-varying Doxy (Fig. 3a;
Supplementary Movie 1), TMP (Fig. 3b; Supplementary Movie 2),
and Doxy/TMP (Fig. 3c; Supplementary Movie 3). We found that
the control action fails in controlling DDmCherry levels to reach
and maintain the set-point when only modulating gene
transcription (Fig. 3a; Supplementary Movie 1; Supplementary
Table 3 and Note 2) or protein stability (Fig. 3b; Supplementary
Movie 2; Supplementary Table 3 and Note 2), whereas a vastly
improved control is achieved when both TMP and Doxy are
applied (Fig. 3c; Supplementary Movie 3; Supplementary Table 3
and Note 2). Importantly, cells reach the set-point with faster
dynamics than those previously observed using a Tet-Off
system25.
We compared the control performance modulating mCherry
transcriptional rate in EF1a-rtTA_TRE3G-DDmCherry mESCs,
but keeping the mCherry protein destabilised (i.e. in absence of
TMP) both before and during the time-lapse control experiment
(Fig. 3d; Supplementary Movie 4); we found a comparable control
performance as when controlling the system with both inducers
(Supplementary Table 3 and Note 2). This indicates that
controlling a destabilised protein at transcriptional level only is
a good strategy for set-point regulation, as previously shown25.
Nevertheless, with a time-varying, multi set-point staircase
reference (Fig. 3e, f; Supplementary Movies 5, 6) and inputs as
in Fig. 3c, d experiments (i.e. Doxy/TMP for over-night activation
and as control input, or Doxy for over-night activation and as
control input, respectively), the control performance was superior
when controlling the system at both transcriptional and post-
translational levels (Supplementary Table 3 and Note 2). As
aforementioned, in absence of TMP, the maximal EF1a-
rtTA_TRE3G-DDmCherry mESC induction with Doxy is lower
(Supplementary Fig. 2d); indeed, in microscopy/microfluidics
experiments, we had to adapt settings to appreciate a good
fluorescence signal, comparable to Doxy/TMP induced cells and
informative for online protein quantification (Supplementary
Note 2). Therefore, while the fluorescence signal is normalised to
1 for maximal induction, the actual absolute values of the multi
Fig. 2 Steady-state/dynamic response and dynamic range of the dual-input system. a mCherry protein levels in EF1a-rtTA_TRE3G-mCherry mESCs
following 24 h of treatment with increasing concentration of Doxy (0; 1; 5; 50; 100; 500; 1000 ng/mL). b, c DDmCherry protein levels measured in EF1a-
rtTA_TRE3G-DDmCherry following 24 h of treatment with increasing concentration of Doxy (0, 1, 5, 50, 100, 500, 1000 ng/mL) and maximum TMP
(10 μM) (b), or increasing concentration of TMP (0, 1, 10, 100 nM; 1, 10 μM) and maximum Doxy (1000 ng/mL) (c). d, e Dynamic response of EF1a-
rtTA_TRE3G-mCherry (d) and EF1a-rtTA_TRE3G-DDmCherry (e) mESCs to Doxy (1000 ng/mL) or Doxy/TMP (1000 ng/mL and 100 nM, respectively) in
a time-course experiment of 38 h, in which inducers were washed out after incubation in the first 14 h. The dots are experimental data of MFI
(Supplementary Fig. 2a–d) measured by flow cytometry and normalised over the maximum activation point. Dashed lines represent model fitting of steady-
state data (a–c RMSE 0.0558 in a, 0.0369 in b, 0.0534 in c) or model prediction of switch-off dynamics (d, e RMSE 0.1590 in d, 0.1773 in e). f Simulated
steady-state of EF1a-rtTA_TRE3G-DDmCherry mESCs upon combined treatment with Doxy and TMP at various concentrations. DDmCherry simulated
values are shown as heatmaps of scaled values across the entire dynamic range of expression levels. g Experimental validation (dots) of simulations
(bars) in (f), measuring EF1a-rtTA_TRE3G-DDmCherry mESC steady-state following 24 h induction with constant concentration of Doxy (100 ng/mL)
and varying TMP (0, 10 nM; 10 μM), or constant TMP (10 nM) and varying Doxy (0, 50, 1000 ng/mL). Maximum concentrations of Doxy and TMP
(1000mg/mL and 10 μM, respectively) are used as control. Data are means ± SD (n= 3, a–c); ±SEM (n= 3 (d, e); n= 2, (g)). Source data are provided
as a Source Data file
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set-point reference signal are lower for the control experiments in
Fig. 3d, f as compared to those in Fig. 3c, e. This might explain
the different slope in the dynamic response to Doxy addition/
removal, resulting in more evident oscillations around the set-
points, which are anyway inevitable using a Relay control
strategy25 and a relatively long sampling time (60 min to avoid
phototoxicity, Supplementary Note 2).
These results demonstrate that our dual-input control is
preferable for Relay control-based in silico feedback regulation of
gene expression in mammalian cells, and is likely to be suitable
for generating more complex time varying gene-expression
dynamics.
Dual-input control of signalling pathway in mESCs. We then
tested the general applicability our dual-input system for fine-
tuning of signalling pathways. We chose the canonical Wnt sig-
nalling pathway, as its activation levels and spatiotemporal
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Fig. 3 In silico feedback control of gene expression in mESCs. Set-point (a–d) and time-varying (e, f) reference relay control experiments, using inducers
(Doxy 1000 ng/mL and/or TMP 100 nM) as control inputs. In red the measured output (normalised DDmCherry fluorescence), in blue the control
reference fluorescence, set at 50% (a–d) or 50–70% (e, f) of the average maximal induction values measured during the calibration phase (120mins with
continuous Doxy/TMP (a–c, e) or Doxy (d, f) administration). The time-lapse sampling time was set at 60mins. The effectiveness of controlling
transcription (a, d, f), protein stability (b) and both (c, e) was tested: cells received either media with Doxy (a, d, f) or Doxy/TMP (c, e) or TMP (b) when
the measured fluorescence was below the control reference, and plain media (c–f) or TMP (a) or Doxy (b) supplemented media when the measured
fluorescence was above the control reference. The control performance indexes for each control experiment are reported in Supplementary Table 3 and
Note 2. In the experiments in d, f, cells were never pre-treated with the protein stabiliser TMP (i.e. they only received Doxy). Details about feedback control
experiments are in Supplementary Note 2
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including intestinal crypt homoeostasis36–38, somite development
during embryogenesis39, stem cell pluripotency maintenance and
somatic cell reprogramming40–42.
To test the ability of our system to modulate levels of β-catenin,
the main effector of the canonical Wnt pathway35,43, we
generated mESCs stably expressing a fusion protein comprising
the destabilising domain (DD), the mCherry fluorescent protein
and a constitutively active β-catenin (β-cateninS33Y)44, driven by
a doxycycline-inducible promoter (henceforth EF1a-
rtTA_TRE3G-DDmCherryβ-cateninS33Y mESCs, Fig. 4a), in a
wild-type mESC line. As with previous constructs, we found
selective response of exogenous DDmCherryβ-cateninS33Y
mRNA (Supplementary Fig. 4a, b) and protein (Fig. 4a–d;
Supplementary Fig. 4c, d) levels to Doxy and Doxy/TMP
treatment, respectively. To prove functionality of the recombinant
protein, we measured the subcellular localisation of both
endogenous and exogenous forms of β-catenin and found
comparable patterns upon inducer treatment (Fig. 4c, d;
Supplementary Fig. 4c, d). Furthermore, nuclear translocation
of the exogenous protein was detected from western blot on
subcellular fractions (Supplementary Fig. 4e), confirming full
functionality of the conditional protein.
Next, we tested DDmCherryβ-cateninS33Y tunability by run-
ning in silico feedback control experiments, using Doxy/TMP as
time-varying inputs as they allowed robust set-point regulation in
EF1a-rtTA_TRE3G-DDmCherry mESCs (Fig. 3c). In presence of
concentrations of Doxy (1000 ng/mL) and TMP (100 nM) used in
previous feedback control experiments (Fig. 3c, e), DDmCherryβ-
cateninS33Y protein levels were stable and never reached the
desired set-point (Supplementary Fig. 4f; Supplementary Movie 7;
Supplementary Table 3 and Note 2), in contrast with the
experiment in Fig. 3c, likely due to different protein half-life and
size of the DDmCherry as compared to the DDmCherryβ-
cateninS33Y 41. Therefore, we performed titration experiments of
EF1a-rtTA_TRE3G-DDmCherryβ-cateninS33Y mESCs (Supple-
mentary Fig. 4g) and consequently selected lower concentrations
of Doxy (100 ng/mL) and TMP (10 nM), still enabling full
activation but possibly easier to be washed-out from cells, to run
set-point control experiments. Lower concentration of inducer
molecules allowed robust feedback control (Fig. 4e; Supplemen-
tary Movie 8; Supplementary Table 3 and Note 2), demonstrating
that control of biologically relevant proteins is possible and that,
irrespectively of half-life and protein turnover, our system can
fine tune gene-of-interest levels.
To study the biological relevance of the inducible
DDmCherryβ-cateninS33Y protein, we took advantage of a mESC
line deleted for endogenous β-catenin gene we generated (β-
catenin−/− mESCs)45, and tested whether it was able to rescue the
impaired clonogenicity and survival of β-catenin null mESCs
grown in absence of the Leukaemia Inhibitory Factor (LIF)45–47.
We stably transduced β-catenin−/− mESCs45 with the EF1a-
rtTA_TRE3G-DDmCherryβ-cateninS33Y plasmids (henceforth
C1-EF1a-rtTA_TRE3G-DDmCherryβ-cateninS33Y mESCs). As
with previous constructs, we found selective dose-response of
exogenous DDmCherryβ-cateninS33Y mRNA (Supplementary
Fig. 4h, i) and protein (Supplementary Fig. 4j–l) levels to Doxy
and Doxy/TMP treatment, respectively. We also measured the
levels of total, cytosolic and nuclear DDmCherryβ-cateninS33Y
protein upon induction by western-blot (Supplementary Fig. 4m).
All extracts showed an increase in the amount of DDmCherryβ-
cateninS33Y, when cells were Doxy/TMP treated (Supplementary
Fig. 4m), consistent with flow cytometry data (Supplementary
Fig. 4l). As compared to β-catenin amount in wild-type cells, only
in nuclear extracts inducible DDmCherryβ-cateninS33Y levels are
above the endogenous ones (Supplementary Fig. 4m, Nuclear);
this observation is coherent with the constitutive active form of
the protein we used, which is insensitive to the endogenous
degradation machinery and therefore accumulates into the
nucleus more than the native β-catenin.
To investigate the effect of DDmCherryβ-cateninS33Y over-
expression, we performed a clonogenicity assay in 5 different
culture conditions following LIF withdrawal. C1-EF1a-rtTA_-
TRE3G-DDmCherryβ-cateninS33Y mESCs were exposed to TMP
10 µM and increasing concentrations of Doxy (10–100 ng/mL;
Supplementary Fig. 4n), and pluripotent colonies were detected
by Alkaline Phosphatase (AP), which only stains cells retaining
the pluripotent phenotype48 (Methods). When uninduced cells
were cultured in serum- and LIF-free media, as previously
reported46,47, the number of AP positive cells was null or the
signal was faint, while in NDiff-Chiron/PD, NDiff-Chiron and
NDiff-PD media supplemented with TMP10 µM and Doxy10 ng/
mL, but not Doxy 100 ng/mL, some AP+ colonies appeared,
rescuing the impaired phenotype (Supplementary Fig. 4o). These
results, while confirming the previous observation of LIF
dependency in β-catenin-deficient mESCs46,47, indicate that
levels of exogenous β-catenin need to be kept within a certain
threshold for rescuing pluripotency, as excessive amounts most
likely could instead promote cells differentiation42.
Finally, to demonstrate the general applicability of our dual-
input system, we applied it to control two proteins not tagged
with fluorescent reporters, specifically β-cateninS33Y and its
transcriptional partner Lymphoid enhancer binding factor1
(Lef1)49,50. We generated mESCs stably expressing the transacti-
vator and a conditionally destabilised β-cateninS33Y (DDβ-
cateninS33Y) protein in β-catenin−/− mESCs (henceforth EF1a-
rtTA_TRE3G-DDβ-cateninS33Y, Fig. 4f) or the conditionally
destabilised Lef1 (DDLef1) protein in wild-type mESCs (hence-
forth EF1a-rtTA_TRE3G-DDLef1, Fig. 4g). Consistently with our
previous observations, DDβ-cateninS33Y (Supplementary Fig. 4p)
and DDLef1 (Supplementary Fig. 4q) mRNA got activated upon
Doxy treatment and did not change in presence of TMP; protein
levels varied as expected at steady-state upon induction (i.e.
titration experiments in Fig. 4h, i) and in switch-off time courses
(Fig. 4j, k). Immunofluorescence staining also confirmed
adequate DDβ-cateninS33Y (Supplementary Fig. 4r, s) and
DDLef1 (Supplementary Fig. 4t, u) protein induction and correct
subcellular localisation.
These findings open potential avenues for dynamic control of
protein expression in stem cells.
Discussion
Complex time-varying patterns of gene expression underlie
numerous biological processes such as immune regulation and
cell fate choice51,52; mimicking and perturbing these profiles of
expression requires tools that faithfully recapitulate often fluctu-
ating kinetics.
In this study, we presented an enhanced tool for conditional gene
expression regulation in mammalian cells encompassing a Tet-On
3G system combined with DD technology that allows fast, specific,
reversible and tunable perturbation of biological macromolecules.
While these and related systems had already been proposed in the
literature, their combination had not been fully explored previously.
We demonstrated experimentally and with a computational
model that by incorporating control at the transcriptional level, as
well as regulating protein-of-interest stability, allows a much finer
and tighter control of gene expression kinetics as compared to
transcriptional or post-translational control alone. Indeed, in our
system genes of interest can be robustly induced but also more
rapidly switched off, likely by enhanced proteasomal degradation
of the translated protein, compared to either stand-alone tran-
scriptional or post-translational control. While it is true that
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inducible transcription of a constitutively destabilised protein
could be also used (e.g. fused to Ubiquitin)53, for some proteins
maximising constitutively the degradation kinetics might impair
the relative biological function; furthermore, the maximal
expression level and, consequently, the dynamic range of the
protein will also be diminished, as we showed when treating
EF1a-rtTA_TRE3G-DDmCherry mESCs with Doxy only (Sup-
plementary Fig. 2d).
These results are in line with the different dynamic range of a
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tTA, and measuring the response of a target gene driven by a TRE
promoter54. Our system, thanks to conditional protein regulation,
allows modulation of protein stability and, consequently, of
the system dynamic range and On-Off dynamics without
requiring the engineering of different constructs and cell lines.
We showed reduced cell-to-cell variability in single cell
induced response when controlling both transcription and pro-
tein stability, as compared to a Tet-on system; in light of recent
results in mammalian cells indicating strong variability in protein
degradation rates in isogenic and phenotypically homogeneous
populations, with consequent effect on extrinsic noise55, we
suggest that conditional protein regulation could be further tested
for noise modulation. Single-cell experiments comparing how
conditional regulation of mRNA and/or protein dynamics can
affect both intrinsic and extrinsic noise56 might be interesting
avenues for future research into origins and tunabilty of cellular
noise, and its effects on cellular phenotypes.
Inducible promoters enable transcriptional regulation and,
combined with systems for controlled protein levels modulation,
provide valuable tools for controlling the expression rate and
amount of proteins of interest. The plant derived AID (auxin-
inducible degradation) system has been recently used to get fast
and efficient proteasomal degradation of AID-tagged proteins in
response to auxin hormones57. However, rates of AID-mediated
protein degradation/recovery strongly depend not only on auxin
uptake and metabolism, but also on the abundance of SCF
complex components, which might vary among different biolo-
gical systems58,59. Therefore, we believe that the AID system is
more suitable for protein knockout experiments instead of fine
temporal control of fused-protein levels. Of note, in yeast and
humans it has also been noted a reduction in the amount of AID-
fused proteins in absence of auxin, suggesting premature protein
degradation in cells expressing the auxin responsive F-box pro-
tein, Tir160,61. We tested AID-mediated protein degradation by
stably introducing in mESCs a plasmid containing both the
OsTir1 (CAG-OsTir1-V5–2A-PuroR) and a miniAID-fused
mCherry (EF1a-mCherrymAID; Supplementary Fig. 5a) in
combination with a Cas9 expression vector for single copy
insertion57,60,62. Although drug-selected, the percentage of
mCherry expressing cells were barely detectable by flow cyto-
metry (Supplementary Fig. 5b) and, when analysed by confocal
microscopy, showed aberrant patterning of the fusion protein
(Supplementary Fig. 5c). We confirmed correct expression of the
OsTir1 by western-blot but failed in detecting any mCherry signal
(Supplementary Fig. 5d). These results are in agreement with
previous findings about premature AID-fused protein
degradation in absence of the auxin analog Indole-3-acetic acid
sodium salt (IAA)60,61. To exclude the observed phenotype was
cell-specific, we carried out a transient experiment in
HEK293T cells. We transfected cells with untagged mCherry- or
mCherrymAID-carrying plasmids, and monitored fluorescent
protein expression and distribution by western-blot and confocal
microscopy. Two days after transfection, mCherrymAID levels
were almost undetectable as compared to cells carrying the
untagged mCherry (Supplementary Fig. 5e, f); even when
increasing laser settings, we could only detect small protein
aggregates (Supplementary Fig. 5f) and mCherrymAID levels
were much lower than those of the untagged mCherry (Supple-
mentary Fig. 5g), indicating basal protein degradation in absence
of IAA. All together, these results showed the AID system has
some limitations impeding further experiments of dynamic pro-
tein control, and tagging of endogenous proteins for which
localisation is important (e.g. β-catenin). In contrast, the desta-
bilisation domain we applied in this study shows good stability in
presence of the inducer molecule TMP, and requires minimal
genetic manipulations of the recipient cellular system58,59. Fur-
thermore, as the inducer stabilises the protein, the dynamic range
of the inducible system can be fully controlled to obtain ‘on-
demand’ activation levels.
We demonstrated that our dual-input regulation system is
suitable for microfluidics/microscopy-based in silico feedback
control: it outperforms transcriptional- and post-translational-
only manipulation to reach and maintain both set-point and
time-varying multi set-point control references, even using a
simple and model-free control strategy. Using more advanced
control strategies, such as Model Predictive Control63, might
overcome limitations of transcriptional- or post-translational-
only regulation, and avoid oscillations that we and others25
reported when using a Relay strategy; nevertheless, such con-
trollers require a mathematical model of the system, not always
available.
Our system suits generation of temporal patterns of gene
expression that traditionally have not been easy to manipulate.
For instance, we demonstrated that finely tuned levels of Wnt/β-
catenin pathway genes (i.e. β-catenin and Lef1) are achievable,
despite the half-life of the tagged proteins, and can exert specific
functions on mESC pluripotency. The canonical Wnt pathway is
known to display oscillating patterns of gene expression in stem
cells and in the developing embryo39–41, which are a key deter-
minants of cell fate determination. This suggests that more
complex dynamic patterns of Wnt-pathway activation could be
engineered; mimicking in silico native temporal patterns should
Fig. 4 Dual-input control of β-catenin and Lef1 levels in mESCs. a, left panel, f, g Dual-input regulation system consisting of the reverse transactivator
(rtTA) and the conditionally destabilised β-cateninS33Y (tagged or not with mCherry, a left panel and f, respectively), or Lef1 (g). a, right panel
Representative flow cytometry profile of Doxy and/or TMP treated EF1a-rtTA_TRE3G-DDmCherryβ-cateninS33Y mESCs. b DDmCherryβ-cateninS33Y
protein levels measured by western blot in EF1a-rtTA_TRE3G-DDmCherryβ-cateninS33Y mESCs treated with Doxy and/or TMP; mCherry (upper panel)
and β-catenin (lower panel) antibodies were used. Asterisk indicates a non-specific band. c, d β-catenin immunostaining in EF1a-rtTA_TRE3G-
DDmCherryβ-cateninS33Y mESCs treated for 24 h with TMP (c) or Doxy/TMP (d), using mCherry (red signal) and β-catenin (green signal) antibodies.
DAPI was used to stain the nuclei. Zoomed pictures of selected clones are shown. Scale bars 25 μm. a–d Doxy and TMP were used at 1000 ng/mL and
100 nM, respectively. e Set-point relay control experiment, using inducers (Doxy 100 ng/mL and TMP 10 nM) as control inputs. In red the measured
output (normalised mCherry fluorescence), in blue the reference fluorescence, set at 50% of the average values measured during the calibration phase
(120mins with continuous Doxy/TMP administration). The control performance indexes are reported in Supplementary Table 3 and Note 2; details about
feedback control implementation are in Supplementary Note 2. h, i DDβ-cateninS33Y (h) and DDLef1 (i) protein levels measured by western blot in EF1a-
rtTA_TRE3G-DDβ-cateninS33Y (h) and EF1a-rtTA_TRE3G-DDLef1 (i) mESCs following 24 h of treatment with increasing concentration of Doxy (0, 1, 5, 50,
100, 500, 1000 ng/mL) and maximum TMP (10μM), or increasing concentration of TMP (0, 1, 10, 100 nM; 1, 10 μM) and maximum Doxy (1000 ng/mL).
Samples induced with the maximal concentration of inducers (Doxy1000ng/mL and TMP10μM) were loaded only once. j, k Dynamic response of EF1a-
rtTA_TRE3G-DDβ-cateninS33Y (j) and EF1a-rtTA_TRE3G-DDLef1 (k) mESCs to Doxy/TMP in a time-course experiment of 38 h, in which inducers were
washed out after 14 h incubation. The concentration of inducer molecules used are Doxy 100 ng/mL and TMP 10 nM (j) or Doxy 1000 ng/mL and TMP
100 nM (k). Source data are provided as a Source Data file
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be compatible with the On-Off kinetics we measured, given the
relatively slow period and amplitude of oscillations observed
in vivo39. Our platform, which has the potential to allow a
quantitative assessment of the molecular mechanisms and
dynamics underpinning cell fate choices, paves the way for con-
trolling cellular behaviour in clinically relevant model systems,
such as stem cells.
The inducibility of our system makes it a powerful perturbation
method, and the ability to tune protein levels with a high degree
of predictability (as evidenced by our faithful capture of system
dynamics using a computational model) makes it a valuable
resource with a broad scope of applications. For instance, it could
be harnessed to study how signalling networks or synthetic gene
circuits are wired together, by fine manipulation of one ‘node’ in
the network and observing how this affects other cognate mem-
bers within the circuit. Ultimately, this approach could be used to
deconvolute and quantitatively assess the interactions within
these networks, which could both explain and predict the con-
sequences of a given perturbation. The mathematical model we
fitted and validated could be used to test the design of new
synthetic networks based on inducible promoters and destabi-
lising domains23,64,65.
Finally, the ability of both Doxy and TMP to cross the placental
barrier66 opens up the possibility that our dual-input system
could allow fine-tuning of genes and signalling pathways essential
in embryonic development, and could be applicable as a novel
approach for targeted gene therapy.
Methods
Inducible constructs. pLVX_EF1a-Tet3G Neo (in the manuscript referred as
EF1a-rtTA) and pLVX_TRE3G Puro were purchased from Clontech (631363).
DHFR-derived destabilization domain (DD), mCherry and β-cateninS33Y were
PCR amplified from pOddKS67, 7TGC68 (Plasmid #24304) and pMXs-beta-
catenin-S33Y (Plasmid #13371) plasmids, respectively. Lef1 cDNA was amplified
from total RNA extracted from mouse embryonic stem cells using SuperScript III
first strand cDNA synthesis kit. The reverse transcriptase reaction was primed with
a reverse oligo annealing to the 3′ end of Lef1 CDS (5′-TCAGATGTAGGCAG
CTGTCA-3′). Five microlitre of the reverse transcription reaction were used to
amplify Lef1 using the following oligos: For: 5′-ATGCCCCAACTTTCCGGAG
G-3′ Rev- 5′-TCAGATGTAGGCAGCTGTCA −3′). Following manufacturer’s
instructions, fragments were assembled into pLVX_TRE3G Puro (Clontech) and
linearised with SmaI (NEB) using HiFi-DNA assembly cloning kit (NEB).
pLVX_TRE3G-DDmCherry is available on Addgene (Plasmid #108679). EF1a
mCherrymAID fusion was cloned into pEN396 (Addgene #92142) linearised with
NotI through Gibson Assembly to generate the all-in-one vector expressing CAG-
Tir1 and EF1a-mCherrymAID fusion protein. mAID was amplified from pMK289
(Addgene #72827).
Cell line derivation. Stable cell lines were generated by lentiviral infection of R1
(EF1a-rtTA_TRE3G-mCherry, EF1a-rtTA_TRE3G-DDmCherry, EF1a-DDrtTA_-
TRE3G-mCherry, EF1a-DDrtTA_TRE3G-DDmCherry and EF1a-rtTA_TRE3G-
DDLef1), E14Tg2a (EF1a-rtTA_TRE3G-DDmCherryβ-cateninS33Y) and
β-catenin−/−45 (EF1a-rtTA_TRE3G-DDmCherryβ-cateninS33Y and EF1a-
rtTA_TRE3G-DDβ-cateninS33Y) mouse embryonic stem cells (mESCs) adapting
the protocol used in ref. 69. Briefly, 7 × 105 HEK293T cells were seeded in a 6-
well plate 24 h before the transfection in Dulbecco’s modified Eagle’s medium
supplied with 10% FBS (Life Technologies), 10 U/mL penicillin, 10 μg/mL strep-
tomycin, 2 mM glutamine, 1 mM sodium pyruvate, and 1x nonessential amino
acids. The day after cells were co-transfected with 1 μg of each specific expression
vector, 0.75 μg of psPAX.2, and 0.25 μg of pMD2.9 packaging plasmids. Twenty-
four h after transfection, cells were switched from HEK293T to mESCs growth
medium, and the media was collected after additional 24 and 48 h and used to
infect recipient mESCs (5 × 104 seeded 24 h before the first infection in a 6-well
plate). mESCs were firstly infected with the stable (EF1a-rtTA) or conditionally
destabilised (EF1a-DDrtTA) transactivator containing vector. After Neomycin
selection, cells were subjected to a second round of infection with the doxycycline-
inducible vector (pLVX_TRE3GmCherry, DDmCherry, DDmCherryBcatS33Y,
DDBcatS33Y or DDLef1) and Puromycin selected. Finally, for fluorescence-tagged
plasmids only, to enrich for mCherry expressing cells and to homogenise mCherry
levels across cell lines, we sorted mCherry positive cells after Doxy or Doxy/TMP
(1000 ng/mL and 10 μM, respectively) 24 h treatment. mESCs were cultured on
gelatin coated dishes in knockout Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 20% fetal bovine serum (Sigma), 1 x nonessential amino acids,
1 x GlutaMax, 1 x2-mercaptoethanol and 1000 U/mL LIF (Peprotech).
For the AID system experiments, R1 mESCs were co-transfected with the all in-
on-one vector expressing the CAG-OsTir1- V5-2A-PuroR and the EF1a-
mCherrymAID fusion protein, and the Cas9 expression vector for targeted single
copy integration in the TIGRE locus. Cells were puromycin selected for 3 weeks
and expanded. HEK293T cells were transfected with the all in-on-one vector
expressing the CAG-OsTir1- V5-2A-PuroR and the EF1a-mCherrymAID fusion
protein or with the CAG-mCherry plasmid, and analysed 2 days upon transfection.
Wild-type mESCs used in this study were kindly provided by Prof Austin Smith, β-
catenin−/− mESCs were derived in the laboratory of Dr Maria Pia Cosma45, HeLa
(HeLa CCL-2) and HEK293T (CRL-11268) cells were directly purchased from
ATCC. Cell lines were tested for mycoplasma.
Flow activated cell sorting (FACS). Cells were washed with sterile phosphate-
buffered saline (PBS, Gibco), trypsinised for 2–3′ at room temperature and cen-
trifuged at 1000 × g for 5′. Pelleted cells were resuspended in 500 μL of complete
mESCs media supplemented with DAPI. The mCherry positive fraction was sorted
from DAPI negative using the BD Influx high-speed 16-parameter fluorescence
activated cell sorter; the gating strategy was defined to get comparable mCherry
intensity across cell lines. For single cells sorting, cells were prepared as previously
and individually sorted in one well of a 96-wellplate in standard culture medium.
Flow cytometry analysis. Cells from a 24-well plate were washed with sterile
Phosphate-Buffered Saline (PBS, Gibco), incubated with 50 μL of trypsin for 2–3′ at
room temperature and collected with 150 μL of PBS 2% FBS containing DAPI as
cell viability marker. Cell suspension was analysed using the BD LSR Fortessa and
10,000 living cells were recorded for each sample. Both % of mCherry positive cells
and Median Fluorescence Intensity (MFI) were calculated over living cells, gated as
DAPI negative.
Drug treatments. Drugs used in this study are doxycycline (Sigma, D9891-1G),
TMP (Sigma, T7883), cycloheximide (Sigma, C4859) and MG132 (Tocris, 1748).
Concentrations and time of treatment are specified in main text and figure legends.
qPCR. For quantitative PCR, the total RNA was extracted from cells using the
RNeasy kit (Qiagen), and the cDNA was generated from 1 μg of RNA. Twenty-five
ng of cDNA were used as template for each qPCR reaction, in a 15 μL reaction
volume. iTaq Universal SYBR Green Supermix (1725120, Bio-Rad) was used with
Qiagen Rotor-Gene System. The primers used were: Actin-Fwd: ACGTTGACAT
CCGTAAAGACCT, Actin-Rev: GCAGTAATCTCCTTCTGCATCC; mCherry-
Fwd: GAACGGCCACGAGTTCGAGA, mCherry-Rev: CTTGGAGCCGTACATG
AACTGAGG; β-catenin-Fwd: CGACACTGCATAATCTCCTGCTCC, β-catenin-
Rev: GGTCCACCACTGGCCAGAATGAT; Lef1-Fwd: CCCACACGGACAGTGA
CCTA, Lef1-Rev: TGGGCTCCTGCTCCTTTCT.
Biochemical analysis. mESC cell lines were treated as detailed in the text and
figure legends; Doxy and TMP are specified in the latter; cycloheximide was used at
25 μg/mL. Cells were lysed in lysis buffer (1% TX-100, 150 mM NaCl, 15 mM Tris
pH 7.5 and protease inhibitors) before processing by SDS-PAGE and western-
blotting. For proteasomal inhibition experiments, MG132 (5 μM) was added 6 h
prior to lysis. Antibodies used are anti-mCherry (AB0040-200, Sicgen, 1:10,000),
anti-β-catenin, clone 14 (610153, BD Biosciences, 1:5000) anti-GAPDH, clone 6C5
(ab8245, Abcam, 1:10,000), anti-Tubulin, clone YOL1/34 (sc-53030, Santa Cruz,
1:2000), anti-Actin (ab8226, Abcam, 1:2000), anti V5, clone D3H8Q (13202, Cell
Signaling, 1:1000), anti Lef1, clone C12A5 (2230, Cell Signaling, 1:2000), anti
HDAC3 (ab7030, abcam, 1:000). Image densitometry was carried out using ImageJ.
Ubiquitination analysis. Cells were drug treated as specified in the text and figure
legends, with Doxy (1000 ng/mL) and TMP (100 nM) for 24 h and chased for 12 h
with or without TMP in the presence of MG132. Cells were then lysed in dena-
turing lysis buffer (2% SDS, 0.5 % NP40, 15 mM Tris pH 6.8, 5% glycerol, 150 mM
NaCl) to prevent deubiquitination, before dilution in modified RIPA buffer
(25 mM Tris pH7.2, 150 mM NaCl, 1% NP40, 0.5 % Sodium Deoxycholate, 1 mM
EDTA) to dilute the SDS to 0.1%. Samples were then immunoprecipitated with
2 μg of anti-ubiquitin antibody (P4D1, Cell Signaling) for 4 h before addition of
Protein G for a further 1 h, followed by extensive washing and processing via SDS-
PAGE and western-blotting with anti-mCherry antibody (AB0040-200, Sicgen).
Immunostaining. Cells were washed twice with PBS, fixed with 4% paraf-
ormaldehyde for 15 mins at RT, and blocked in PBS with 0.1% Triton X-100 and
3% BSA, for 60 mins. Cells were incubated overnight with the specific primary
antibody in PBS with 0.1% Triton X-100 and 1% BSA.
Cells where PBS washed for three times (5′ each wash) before being incubated
with the secondary antibody conjugated with fluorescein for 1 h at room
temperature. Finally, cells were washed and mounted on slides with a few drops of
Vectashield, with DAPI (Vector Laboratories). The primary antibodies used for
immunostaining are: anti-β-catenin, clone 14 (610153, BD Biosciences), working
concentration 1:1000; anti-mCherry (AB0040-200, Sicgen) working concentration
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1:1000; anti Lef1, clone C12A5 (2230, Cell Signaling, 1:1000). The fluorescent
conjugated secondary antibodies were diluted 1:1000.
Nucleus/cytosol fractionation. For Nuclear and Cytosolic protein fractionation,
cells from a 10 cm dish were washed in cold PBS, scraped in 1 mL of cold PBS
using a cell scraper and centrifuged (5 min at 12,000 × g). The supernatant was
discarded, and the pellet resuspended in 900 μL of cold 0.1% NP40 in PBS. Three
hundred microlitre of the suspension was remove as total extract and the
remaining 600 μL centrifuged for 5 min at 12,000 × g. After the centrifugation,
300 μL of supernatant was removed as cytosolic fraction and the remaining
300 μl discarded. The nuclear pellet was washed with 1 mL of cold PBS, cen-
trifuged as above, the supernatant discarded, and the pellet resuspended in
180 μL of 1x Laemmli buffer. Hundred microlitres of 4x Laemmli buffer was
added to both total and cytosolic fractions. Samples were sonicated (level 2
thrice for 10 s each) and boiled for 3 min before being loaded (20 μL of total and
cytosolic and 10 μL on nuclear extracts).
Alkaline phosphatase (AP) assay. At Day1 C1-EF1a-rtTA_TRE3G-DDmCher-
ryβ-cateninS33Y mESCs were plated in 12-well plate to a density of 131cells/cm2 and
cultured for 24 h in standard (i.e. serum enriched) mESC growth media without LIF.
At Day2 cells were switched to different media and cultured for around 1week always
in absence of LIF and with the addition of the inducers TMP+/−Doxy (10 μM and
10–100 ng/mL, respectively). The serum-free media are all based on NDiff22770
(Y40002, Takara) medium supplemented or not with the Mek (PD; PD0325901,
S1036 Selleckchem) and/or the GSK3 (Chiron; CHIR-99021, S1263 Selleckchem)
inhibitors70. At Day 8 from the plating cells were fixed in 10% cold Neutral Formalin
Buffer (NFB) for 15min at 4 °C followed by 15min in distilled water and incubated
for 45–60min (until red colonies are visible) with the Alkaline Phosphatase substrate
containing Naphthol (N4875, Sigma), N,N-Dimethylformamide (DMF, 227056,
Sigma), 0.2M Tris-HCl and Fast Red Violet LB Salt (F3381, Sigma).
Single clone coefficient of variation calculation. As a measure of the mCherry
variation across clones, we calculated the coefficient of variation (SD divided by the
mean value) on the mCherry+ cells for both EF1a-rtTA_TRE3G-mCherry and
EF1a-rtTA_TRE3G-DDmCherry single clones. The coefficient of variation (CV)
indicates how much the single clones deviate from the average. The Higher the CV
value is, the more heterogeneous the cellular response is.
Statistical analysis. Differences between groups were analysed by Student t test
and nonparametric one-way ANOVA using GraphPad Prism (version 8.2.0). A
p-value lower than 0.05 was considered statistically significant.
Data availability
All data presented in this study are available from the corresponding authors upon
reasonable request. Source data are available in the Source Data file.
Code availability
All code used in this study is available from the corresponding authors upon reasonable
request.
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